Jump to content

3C-TFE

Add links
From Wikipedia, the free encyclopedia
(Redirected from 3C-F3EM)

3C-TFE
Clinical data
Other names4-(2,2,2-Trifluoroethoxy)-3,5-dimethoxyamphetamine; 3,5-Dimethoxy-4-(2,2,2-trifluoroethoxy)amphetamine; 3C-F3EM; α-Methyltrifluoroescaline; 3C-Trifluoroescaline
Routes of
administration		Oral[1]
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Pharmacokinetic data
Duration of action15 hours[1]
Identifiers
  • 1-[3,5-dimethoxy-4-(2,2,2-trifluoroethoxy)phenyl]propan-2-amine
PubChem CID
ChemSpider
Chemical and physical data
FormulaC13H18F3NO3
Molar mass293.286 g·mol−1
3D model (JSmol)
  • CC(CC1=CC(=C(C(=C1)OC)OCC(F)(F)F)OC)N
  • InChI=1S/C13H18F3NO3/c1-8(17)4-9-5-10(18-2)12(11(6-9)19-3)20-7-13(14,15)16/h5-6,8H,4,7,17H2,1-3H3
  • Key:UBMKSRMQBSOFBH-UHFFFAOYSA-N

3C-TFE, also known as 4-(2,2,2-trifluoroethoxy)-3,5-dimethoxyamphetamine or as α-methyltrifluoroescaline (3C-trifluoroescaline), is a psychedelic drug of the phenethylamine, amphetamine, and 3C families related to 3,4,5-trimethoxyamphetamine (TMA; 3C-M).[1][2][3] It is a trifluorinated derivative of 3C-E.[1][2][3] The drug's dose is 30 mg and its duration is approximately 15 hours.[1] It shows weak but significant affinity for the serotonin 5-HT2A and 5-HT2C receptors (Ki = 1,825 nM and 1,659 nM, respectively).[1] 3C-TFE was first described in the scientific literature by Daniel Trachsel in 2002.[3][2][1] The pharmacology of a number of 3C drugs was studied in 2021, but 3C-TFE was not one of the included compounds.[4]

See also

[edit]

References

[edit]
  1. ^ a b c d e f g Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. pp. 736–737. ISBN 978-3-03788-700-4. OCLC 858805226.
  2. ^ a b c Trachsel D (2012). "Fluorine in psychedelic phenethylamines". Drug Testing and Analysis. 4 (7–8): 577–590. doi:10.1002/dta.413. PMID 22374819.
  3. ^ a b c Trachsel D (2002). "Synthese von neuen (Phenylalkyl)aminen zur Untersuchung von Struktur-Aktivitätsbeziehungen, Mitteilung 1, Mescalin Derivate". Helvetica Chimica Acta. 85 (9): 3019–3026. doi:10.1002/1522-2675(200209)85:9<3019::AID-HLCA3019>3.0.CO;2-4.
  4. ^ Kolaczynska KE, Luethi D, Trachsel D, Hoener MC, Liechti ME (2021). "Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines". Frontiers in Pharmacology. 12 794254. doi:10.3389/fphar.2021.794254. PMC 8865417. PMID 35222010.
[edit]
Stub icon

This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=3C-TFE&oldid=1317618900"